Rôle de l'enzyme de conversion TNF (TACE/ADAM17) et des protéines associées dans la maladie coronaire et les événements cardiaques

Translated title of the contribution: Role of tumour necrosis factor alpha converting enzyme (TACE/ADAM17) and associated proteins in coronary artery disease and cardiac events

Melody Chemaly, Victoria McGilligan, Mark Gibson, Matthias Clauss, Steven Watterson, H. Denis Alexander, Anthony John Bjourson, Aaron Peace

Research output: Contribution to journalReview article

Abstract

Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFα) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.

Original languageFrench
Pages (from-to)700-711
Number of pages12
JournalArchives of Cardiovascular Diseases
Volume110
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Coronary Artery Disease
Tumor Necrosis Factor-alpha
Atherosclerosis
Receptors, Tumor Necrosis Factor, Type II
Disintegrins
Tumor Necrosis Factor Receptors
Immune System Diseases
Metalloproteases
Arthritis
Proteins
Peptide Hydrolases
Ischemia
Heart Failure
Biomarkers
Research
ADAM17 Protein
Neoplasms
Therapeutics
Clinical Studies

Keywords

  • Atherosclerosis
  • Biomarker
  • TACE
  • TNFα
  • Transmembrane proteins

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Rôle de l'enzyme de conversion TNF (TACE/ADAM17) et des protéines associées dans la maladie coronaire et les événements cardiaques. / Chemaly, Melody; McGilligan, Victoria; Gibson, Mark; Clauss, Matthias; Watterson, Steven; Alexander, H. Denis; Bjourson, Anthony John; Peace, Aaron.

In: Archives of Cardiovascular Diseases, Vol. 110, No. 12, 01.12.2017, p. 700-711.

Research output: Contribution to journalReview article

Chemaly, Melody ; McGilligan, Victoria ; Gibson, Mark ; Clauss, Matthias ; Watterson, Steven ; Alexander, H. Denis ; Bjourson, Anthony John ; Peace, Aaron. / Rôle de l'enzyme de conversion TNF (TACE/ADAM17) et des protéines associées dans la maladie coronaire et les événements cardiaques. In: Archives of Cardiovascular Diseases. 2017 ; Vol. 110, No. 12. pp. 700-711.
@article{4cb9067b374a489b8adde2b3c2bee32b,
title = "R{\^o}le de l'enzyme de conversion TNF (TACE/ADAM17) et des prot{\'e}ines associ{\'e}es dans la maladie coronaire et les {\'e}v{\'e}nements cardiaques",
abstract = "Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFα) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.",
keywords = "Atherosclerosis, Biomarker, TACE, TNFα, Transmembrane proteins",
author = "Melody Chemaly and Victoria McGilligan and Mark Gibson and Matthias Clauss and Steven Watterson and Alexander, {H. Denis} and Bjourson, {Anthony John} and Aaron Peace",
year = "2017",
month = "12",
day = "1",
doi = "10.1016/j.acvd.2017.08.002",
language = "French",
volume = "110",
pages = "700--711",
journal = "Archives of Cardiovascular Diseases",
issn = "1875-2136",
publisher = "Elsevier Masson",
number = "12",

}

TY - JOUR

T1 - Rôle de l'enzyme de conversion TNF (TACE/ADAM17) et des protéines associées dans la maladie coronaire et les événements cardiaques

AU - Chemaly, Melody

AU - McGilligan, Victoria

AU - Gibson, Mark

AU - Clauss, Matthias

AU - Watterson, Steven

AU - Alexander, H. Denis

AU - Bjourson, Anthony John

AU - Peace, Aaron

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFα) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.

AB - Tumour necrosis factor alpha converting enzyme (TACE/ADAM17) is a member of the A disintegrin and metalloproteinase (ADAM) family of ectodomain shedding proteinases. It regulates many inflammatory processes by cleaving several transmembrane proteins, including tumour necrosis factor alpha (TNFα) and its receptors tumour necrosis factor alpha receptor 1 and tumour necrosis factor alpha receptor 2. There is evidence that TACE is involved in several inflammatory diseases, such as ischaemia, heart failure, arthritis, atherosclerosis, diabetes and cancer as well as neurological and immune diseases. This review summarizes the latest discoveries regarding the mechanism of action and regulation of TACE. It also focuses on the role of TACE in atherosclerosis and coronary artery disease (CAD), highlighting clinical studies that have investigated its expression and protein activity. The multitude of substrates cleaved by TACE make this enzyme an attractive target for therapy and a candidate for biomarker research and development in CAD.

KW - Atherosclerosis

KW - Biomarker

KW - TACE

KW - TNFα

KW - Transmembrane proteins

UR - http://www.scopus.com/inward/record.url?scp=85033698074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033698074&partnerID=8YFLogxK

U2 - 10.1016/j.acvd.2017.08.002

DO - 10.1016/j.acvd.2017.08.002

M3 - Review article

VL - 110

SP - 700

EP - 711

JO - Archives of Cardiovascular Diseases

JF - Archives of Cardiovascular Diseases

SN - 1875-2136

IS - 12

ER -